Olink Proteomics Limited
09812227
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/12/2024
small
Next accounts due
30/09/2026
Confirmation statement
Last: 05/10/2025
Due 19/10/2026
Industry
Officers
director · Since 19/08/2024
DIRECTOR
BRITISH · UNITED KINGDOM · Age 46
Also on 174 other boards
director · Since 19/08/2024
DIRECTOR
BRITISH · UNITED KINGDOM · Age 50
Also on 181 other boards
director · Since 19/08/2024
VP, TAX & TREASURY AND TREASURER
AMERICAN · UNITED STATES · Age 64
director · Since 19/08/2024
DIRECTOR
BRITISH · UNITED KINGDOM · Age 49
Also on 148 other boards
Persons with Significant Control
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, 168 Third Avenue, Waltham, 02451
Reg: 558016 · The Delaware Division Of Corporations · Corporate
Notified 22/07/2024
Former PSCs
Olink Holding Ab (Publ)
Ceased 22/07/2024
CompanyRankvs 403+ SIC 72110 peers75
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
£386k
Balance sheet strength
Cash
£1.0M
Cash in the bank
Net Current Assets
£386k
Working capital
Current Assets
£2.4M
Current Liabilities
£2.0M
Fixed Assets
£56
Debtors
£1.4M
Tax at Year End(2023)
People Costs(2021)
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 1.19 | +£314k |
| 2023 | 1.08 | -£31k |
| 2021 | 1.40 | +£16k |
| 2020 | 1.82 | +£37k |
| 2019 | 1.95 | — |
Derived from filed accounts. Not audited figures.